Search - tctmd.com

Displaying 21 - 40 of 260

Sort: Relevancy | Date

News Conference News CRT 2021

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

Todd Neale

March 08, 2021

News Conference News TCT 2020

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

L.A. McKeown

October 22, 2020

Podcast Rox Heart Radio

Rox Heart Radio: From the Front With George Dangas and Ajay Kirtane

April 02, 2020

News Conference News ACC 2020

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Yael L. Maxwell

March 30, 2020

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Todd Neale

November 17, 2019

Presentation TCT 2019

Science Behind Nanolute Technology of Sirolimus-Coated Balloon

Presenter: George Dangas

September 28, 2019

Presentation TCT 2019

ORSIRO: An “Ultra-Thin Strut” Metallic DES With Bioresorbable Polymer

Presenter: George Dangas

September 28, 2019

Presentation TCT 2019

Alternative Approaches for In-Stent Restenosis: Laser, Brachytherapy, Lithotripsy….

Presenter: George Dangas

September 27, 2019

Presentation TCT 2019

Keynote Speech: Heart Valve Therapy 2019 – Importance of the HEART Team

Presenter: George Dangas

September 25, 2019

News Conference News SCAI 2019

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Yael L. Maxwell

June 05, 2019

News Daily News

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Shelley Wood

April 16, 2019

Presentation TCT 2018

Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy

Presenter: George D. Dangas, Giuseppe Tarantini, Roxana Mehran

September 23, 2018

Presentation TCT 2018

Case #2 Conclusion: How Did I Actually Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia

September 23, 2018

Presentation TCT 2018

How Would I Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Ugo Limbruno

September 23, 2018

Presentation TCT 2018

How Would I Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Dominick J. Angiolillo

September 23, 2018

Presentation TCT 2018

Case #2 Introduction: A Patient With Chronic CAD At High Bleeding Risk Requiring PCI

Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia

September 23, 2018

Presentation TCT 2018

Consensus: PCI Considerations In The High Bleeding Risk Patient With Chronic CAD

Presenter: George D. Dangas, Giuseppe Tarantini

September 23, 2018

Presentation TCT 2018

Case #1 Conclusion: How Did I Actually Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia

September 23, 2018

Presentation TCT 2018

How Would I Treat This Patient?

Presenter: George D. Dangas, Giuseppe Tarantini, Alessio G La Manna

September 23, 2018

Presentation TCT 2018

Case #1 Introduction: A High Bleeding Risk Patient With Afib And ACS Requiring PCI And Oral Anticoagulant Therapy

Presenter: George D. Dangas, Giuseppe Tarantini, Steven R. Bailey, Giovanni Esposito, Juan F. Granada, Roxana Mehran, Francesco Saia

September 23, 2018

Advertisement

DOAC Use Increasing in Patients With Bioprosthetic Heart Valves

EXAMINATION Surprise: Few Late Event Gaps Between DES and BMS in STEMI

Rox Heart Radio: From the Front With George Dangas and Ajay Kirtane

Safety, Efficacy of Ticagrelor Monotherapy Confirmed in Complex PCI, Diabetes

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

Science Behind Nanolute Technology of Sirolimus-Coated Balloon

ORSIRO: An “Ultra-Thin Strut” Metallic DES With Bioresorbable Polymer

Alternative Approaches for In-Stent Restenosis: Laser, Brachytherapy, Lithotripsy….

Keynote Speech: Heart Valve Therapy 2019 – Importance of the HEART Team

ProGlide Comes Out Ahead of Prostar in Vascular Closure After Transfemoral TAVR: BRAVO 3

Continuing Anticoagulation During TAVR: New Data Offer a Glimpse of What Works

Consensus: Considerations In The High Bleeding Risk Patient Requiring PCI And Oral Anticoagulant Therapy

Case #2 Conclusion: How Did I Actually Treat This Patient?

How Would I Treat This Patient?

How Would I Treat This Patient?

Case #2 Introduction: A Patient With Chronic CAD At High Bleeding Risk Requiring PCI

Consensus: PCI Considerations In The High Bleeding Risk Patient With Chronic CAD

Case #1 Conclusion: How Did I Actually Treat This Patient?

How Would I Treat This Patient?

Case #1 Introduction: A High Bleeding Risk Patient With Afib And ACS Requiring PCI And Oral Anticoagulant Therapy

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content